abstract |
The invention provides dicarboxylic acid-substituted heteroaryl derivatives of the formula n G 1 -(C(R 1 )R 2 ) n -Q 1 -B-Q 2 -(C(R 3 )R 4 ) m -G 2 I n or a pharmaceutically acceptable salt thereof, wherein G 1 , G 2 , R 1 , R 2 , R 3 , R 4 , n, m, Q 1 , Q 2 , and B are as defined in the specification. The invention compounds are inhibitors of matrix metalloproteinase enzymes, including MMP-13. This invention also provides pharmaceutical compositions and methods of treating diseases mediated by MMP-13, including arthritis, asthma, heart disease, atherosclerosis, and osteoporosis, or a pharmaceutically acceptable salt thereof. |